Simulations Plus Inc (SLP)

11:50 AM

Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Benzinga

11:50 AM

09:00 AM

Simulations Plus partners with Nvidia on AI drug development - Investing.com

09:00 AM

08:22 AM

Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com Nigeria

08:22 AM

08:02 AM

Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com

08:02 AM

07:55 AM

Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - Business Wire

07:55 AM

May 05, 2026

Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus

May 05, 2026

May 05, 2026

[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan

May 05, 2026

May 05, 2026

Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan

May 05, 2026

May 05, 2026

Do options traders know something about Simulations Plus stock we don't? - MSN

May 05, 2026

May 04, 2026

[144] Simulations Plus, Inc. SEC Filing - Stock Titan

May 04, 2026

May 04, 2026

(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

May 04, 2026

May 04, 2026

Do Options Traders Know Something About Simulations Plus Stock We Don't? - TradingView

May 04, 2026

May 01, 2026

Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan

May 01, 2026

May 01, 2026

Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan

May 01, 2026

May 01, 2026

Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan

May 01, 2026

May 01, 2026

Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan

May 01, 2026

May 01, 2026

SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill

May 01, 2026

Apr 29, 2026

AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire

Apr 29, 2026

Apr 29, 2026

AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK

Apr 29, 2026

Apr 27, 2026

Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.

Apr 27, 2026

Apr 27, 2026

Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 27, 2026

Apr 26, 2026

Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan

Apr 26, 2026

Apr 26, 2026

Simulations Plus Q2 2026 earnings preview - MSN

Apr 26, 2026

Apr 23, 2026

Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm

Apr 23, 2026

Apr 23, 2026

(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily

Apr 23, 2026

Apr 23, 2026

Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN

Apr 23, 2026

Apr 22, 2026

SLP Simulations Plus posts strong Q1 2026 results, shares rise over four percent on double digit EPS and revenue gains.Debt/Equity - Xã Thanh Hà

Apr 22, 2026

Apr 22, 2026

Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Nigeria

Apr 22, 2026

Apr 21, 2026

Simulations Plus (SLP) Partners with FDA and Lonza for Drug Perf - GuruFocus

Apr 21, 2026

Apr 21, 2026

Simulations Plus enters funded research collaboration with Lonza, FDA - TipRanks

Apr 21, 2026

Apr 21, 2026

Simulations Plus partners with Lonza and FDA on drug formulation research By Investing.com - Investing.com South Africa

Apr 21, 2026

Apr 21, 2026

Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire

Apr 21, 2026

Apr 21, 2026

Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating - Moomoo

Apr 21, 2026

Apr 20, 2026

Simulations Plus (SLP) Completes Successful Spring School Traini - GuruFocus

Apr 20, 2026

Apr 20, 2026

What Happened to Simulations Plus (SLP) Stock Today (Wavering) 2026-04-20Continuation Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 20, 2026

Apr 20, 2026

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - 01net

Apr 20, 2026

Apr 20, 2026

Simulations Plus Inc Announces Completion of 2026 Spring School Global Training Initiative - marketscreener.com

Apr 20, 2026

Apr 19, 2026

Simulations Plus Reports Strong Fiscal Second Quarter Growth - HarianBasis.co

Apr 19, 2026

Apr 19, 2026

Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development - Insider Monkey

Apr 19, 2026

Apr 19, 2026

Simulations Plus, Children's Place and 3 stocks to watch heading into Friday - MSN

Apr 19, 2026

Apr 18, 2026

Simulations Plus (SLP) Stock Public Float (+1.77%) 2026-04-18Continuation Pattern - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 18, 2026

Apr 17, 2026

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 67.61% Potential Upside in Healthcare Software Solutions - DirectorsTalk Interviews

Apr 17, 2026

Apr 17, 2026

Simulations Plus, Inc. (NASDAQ: SLP) Q2 2026 earnings call transcript - MSN

Apr 17, 2026

Apr 16, 2026

Insider Sell: DiBella John Anthony II Sells Shares of Simulations Plus Inc (SLP) - GuruFocus

Apr 16, 2026

Apr 16, 2026

John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock - MarketBeat

Apr 16, 2026

Apr 16, 2026

DiBella, Simulations Plus CRO, sells $13370 in SLP stock By Investing.com - Investing.com Canada

Apr 16, 2026

Apr 16, 2026

Simulations Plus (SLP) CRO sells 1,000 shares via Rule 10b5-1 plan - Stock Titan

Apr 16, 2026

Apr 15, 2026

HTPK platform from Simulations Plus targets smarter early compound selection at DDC - Traders Union

Apr 15, 2026

Apr 15, 2026

Simulations Plus: Better Quarter, Same Doubts (NASDAQ:SLP) - Seeking Alpha

Apr 15, 2026